AI assistant
ANGIODYNAMICS INC — Director's Dealing 2020
Jul 21, 2020
32939_dirs_2020-07-21_0f6a67af-21c9-4c49-9944-dd940e8dc606.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2020-07-17
Reporting Person: Helsel Dave (SVP Global Operations and R&D)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-17 | Common Stock | F | 254 | $9.46 | Disposed | 23708 | Direct |
| 2020-07-18 | Common Stock | F | 207 | $9.21 | Disposed | 23501 | Direct |
| 2020-07-18 | Common Stock | F | 155 | $9.21 | Disposed | 23348 | Direct |
Footnotes
F1: The exempt disposition of 254 shares of common stock of AngioDynamics, Inc. ("Common Stock") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019.
F2: The exempt disposition of 207 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018.
F3: The exempt disposition of 153 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018.